Microfluidic detection chip, detection method and detection apparatus
By combining microfluidic detection chips and magnetic particles, the automation and simplification of nucleic acid detection have been achieved, solving the problems of complex processes, long time consumption and high risk of contamination in existing technologies, and improving detection efficiency and safety.
Patent Information
- Application Number
- PCT/CN2026/095474
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-15
- Filing Date
- 2026-05-08
- Publication Date
- 2026-11-19
AI Technical Summary
Existing nucleic acid testing technologies are complex, time-consuming, have low automation, require high operating environments, are prone to aerosol contamination, and have high reagent storage and transportation costs, making it impossible to achieve real-time testing.
The microfluidic detection chip includes a substrate, a sealing layer, a sample chamber, a solid reagent chamber, a liquid-filled buffer chamber, a liquid reagent chamber, and a reaction chamber. Nucleic acid extraction and amplification are performed by the movement of magnetic particles in the liquid reagent chamber. The liquid-filled layer is pre-loaded with reagents. Combined with magnetic components and a gas-driven control structure, the operation process is simplified and the risk of contamination is reduced.
It automates and simplifies nucleic acid testing, reduces the probability of contamination, improves biosafety, shortens testing time, and reduces the impact of freeze-thaw cycles on reagents, making it suitable for use in primary healthcare institutions.
Smart Images

Figure CN2026095474_19112026_PF_FP_ABST
Abstract
Description
A microfluidic detection chip, detection method and detection equipment
[0001] This application claims priority to Chinese Patent Application No. 202510626700.X, filed on May 15, 2025, entitled “A Microfluidic Detection Chip, Detection Method and Detection Device”, the entire contents of which are incorporated herein by reference. Technical Field
[0002] This application relates to the field of microfluidic chip technology, and in particular to a microfluidic detection chip, detection method and detection equipment. Background Technology
[0003] In related technologies, microfluidic chips are also known as lab-on-a-chip. Microfluidic chip technology offers advantages such as small sample volume, rapid analysis speed, ease of fabrication into portable instruments, and suitability for point-of-care and on-site analysis, and has been widely applied in many fields including biology, chemistry, and medicine. The combination of microfluidic chips with in vitro diagnostic reagents and technologies has led to the development of numerous rapid detection technologies, such as microfluidic-based colloidal gold immunoassay, immunofluorescence assay, chemiluminescence assay, and microfluidic-based nucleic acid assay.
[0004] Problems faced by existing nucleic acid testing technologies based on strictly partitioned molecular laboratories:
[0005] 1. Complex process and time-consuming operation. Existing nucleic acid amplification technologies (such as PCR (polymerase chain reaction), fluorescent PCR, isothermal amplification, etc.) have complex processes, involving sample processing, nucleic acid extraction, solution preparation, amplification and detection. The process is very complex and requires a lot of manual intervention. The test often takes 4-6 hours or even longer to complete the sample test.
[0006] 2. Low level of automation and high requirements for personnel. The general process of nucleic acid testing mainly involves sample collection, sample processing, nucleic acid extraction, reaction reagent preparation and PCR amplification detection, etc. Each step is based on operation by testing personnel. Some laboratories use automated nucleic acid extraction equipment to replace manual labor, but often only a part of the testing process can be automated, not the whole process. Therefore, it places high demands on the operation skills of the operators.
[0007] 3. High requirements for the operating environment; a professional molecular diagnostic laboratory is necessary. Currently, most nucleic acid testing experiments need to be conducted in a laboratory, and more than one laboratory is required. Nucleic acid testing methods are highly sensitive, which also makes them prone to aerosol contamination and false positive results. Therefore, most laboratories adopt a zoned design, such as setting up reagent preparation rooms, sample processing rooms, amplification rooms, and product analysis rooms. Different areas have different air pressures, and operators complete corresponding operations in different functional areas, strictly adhering to the flow of people and materials in the molecular diagnostic laboratory to prevent aerosol contamination.
[0008] 4. Existing molecular laboratories require large floor space and expensive testing equipment, typically including specialized equipment such as nucleic acid extraction equipment, PCR amplification and detection equipment, and biosafety cabinets. Personnel also require training before operation. These high demands for personnel, space, and funding limit their promotion and use in primary healthcare institutions.
[0009] 5. Most existing nucleic acid testing reagents are stored in liquid form, requiring cold chain transport and low-temperature preservation, which is demanding and costly. Before use, the reagents need to be thawed, then aliquoted, prepared, and tested. This process is cumbersome, and repeated freeze-thaw cycles can negatively impact reagent stability. Furthermore, the reagent aliquoting process is conducted in an open environment, making them susceptible to contamination from external contaminants, thus affecting the accuracy of experimental results.
[0010] 6. Prone to aerosol contamination and low biosafety. Although nucleic acid testing is conducted in professional molecular diagnostic laboratories, the interior of each laboratory is still an open space. When multiple samples are processed simultaneously, aerosols are still inevitably generated. As aerosols accumulate in different rooms and with the movement of people, the risk of contamination is unavoidable over time.
[0011] Furthermore, traditional laboratory testing requires accumulating samples, processing them together, and then testing them on the machine. Therefore, it cannot achieve real-time sample testing, the process is time-consuming, the sample turnaround time is long, patients have to wait for test results for a long time, resulting in a poor patient experience, and it cannot quickly provide test results to medical staff, which is not conducive to rapid diagnosis and treatment of diseases. Summary of the Invention
[0012] This application aims to address at least one of the technical problems existing in the prior art. To this end, this application proposes a microfluidic detection chip, detection method, and detection device, which can effectively simplify the detection steps, reduce the probability of contamination during the detection process, and improve biosafety.
[0013] An embodiment of the first aspect of this application provides a microfluidic detection chip, comprising:
[0014] A microfluidic layer includes a substrate and a top sealing layer and a bottom sealing layer located on both sides of the substrate. The substrate is provided with a sample chamber, a solid reagent chamber, a liquid bladder buffer chamber, a liquid reagent chamber, a reagent buffer chamber, and a reaction chamber. The sample chamber is connected to the solid reagent chamber through a flow channel. There are multiple liquid bladder buffer chambers, which are independently arranged. There are multiple liquid reagent chambers, which are arranged sequentially at intervals. At least one reagent buffer chamber is arranged between two adjacent liquid reagent chambers.
[0015] The first liquid reagent chamber at the front end is connected to the solid reagent chamber via a flow channel, and the liquid reagent chamber at the end end is connected to the reaction chamber via a flow channel; one of the liquid bladder buffer chambers is in fluid communication with one of the sample chamber and the first liquid reagent chamber; except for the first liquid reagent chamber at the front end, each of the remaining liquid reagent chambers is connected to a different liquid bladder buffer chamber via a flow channel.
[0016] The puncture structure is provided in each of the liquid bladder buffer cavities;
[0017] A liquid bladder layer is disposed on one side of the substrate. The liquid bladder layer includes a plurality of spaced and independent liquid bladder units. Each liquid bladder unit has a liquid bladder cavity, and the liquid bladder cavity of the liquid bladder unit is disposed opposite to at least one of the puncture structures.
[0018] Furthermore, the substrate is provided with a first gas connection hole and a first shut-off valve. The first gas connection hole is in fluid communication with the second liquid reagent chamber located at the front end, and the first shut-off valve is used to control the opening and closing of the flow channel connected to the liquid inlet end of the reaction chamber.
[0019] Furthermore, the substrate is provided with a mixing channel and a mixing chamber. One end of the mixing channel is in liquid communication with the liquid reagent chamber located at the end, and the other end of the mixing channel is in liquid communication with the inlet end of the mixing chamber. The outlet end of the mixing chamber is in liquid communication with the inlet end of the first shut-off valve.
[0020] Furthermore, the substrate is provided with a test strip receiving cavity, an air hole, a second shut-off valve, and a third shut-off valve. The test strip receiving cavity is in liquid communication with the liquid outlet of the reaction chamber through a flow channel, and the air hole is in fluid communication with the liquid outlet of the reaction chamber through a flow channel. The second shut-off valve is used to control the opening and closing of the flow channel between the liquid outlet of the reaction chamber and the air hole, and the third shut-off valve is used to control the opening and closing of the flow channel between the test strip receiving cavity and the liquid outlet of the reaction chamber.
[0021] Furthermore, the substrate is provided with a fourth shut-off valve, a quantitative mixing chamber, and a second gas connection hole. The fourth shut-off valve is disposed on a flow channel that communicates with the liquid inlet end of the first shut-off valve. The quantitative mixing chamber hole of the quantitative mixing chamber is in fluid communication with the liquid outlet end of the fourth shut-off valve. The top of the quantitative mixing chamber is connected to the second gas connection hole through a flow channel.
[0022] Furthermore, the reaction chamber is flat, and at least one cavity is provided on the outer periphery of the reaction chamber.
[0023] Furthermore, the number of reaction chambers is at least one.
[0024] Furthermore, the substrate includes a first part and a second part that are interconnected, the thickness of the second part is less than the thickness of the first part, the reaction chamber is disposed in the second part, and the reaction chamber is disposed through the upper end face and the lower end face of the second part.
[0025] Furthermore, the liquid bladder unit includes a liquid bladder shell and a liquid bladder sealing membrane, the liquid bladder shell forming an open liquid bladder cavity, and the liquid bladder sealing membrane being disposed on the side of the liquid bladder cavity with the open.
[0026] An embodiment of the second aspect of this application provides a detection method applied to the microfluidic detection chip as described above, the detection method comprising the following steps:
[0027] Place the biological sample into the sample chamber and close the sample chamber;
[0028] Squeeze the liquid capsule unit connected to the sample cavity to allow the reagent in the liquid capsule unit to flow into the sample cavity and mix with the biological sample;
[0029] The mixed solution in the sample chamber is driven to flow to the solid reagent chamber to redissolve the solid reagent preset in the solid reagent chamber to obtain a mixture, wherein the solid reagent chamber is also preset with magnetic particles;
[0030] The mixture in the solid reagent chamber is forced into the first liquid reagent chamber and allowed to stand.
[0031] The first and second magnetic components are controlled to approach the top and / or bottom of the liquid reagent chamber, and the first and second magnetic components are used to drive the magnetic particles in the liquid reagent chamber to pass through each of the liquid reagent chambers and the reagent buffer chamber in sequence, and drive the magnetic particles to finally move to the liquid reagent chamber located at the end.
[0032] Maintaining the adsorption state of the magnetic particles by the first magnetic element, the elution product in the liquid reagent chamber at the end is driven into the reaction chamber to carry out the amplification reaction.
[0033] An embodiment of the third aspect of this application provides a detection device, including:
[0034] At least one pressure structure is used to compress the individual liquid bladder units of the liquid bladder layer;
[0035] A magnetic component, comprising a first magnetic element and a second magnetic element spaced apart;
[0036] A driving device is used to drive a first magnetic component to move, such that the first magnetic component moves in a direction perpendicular to the microfluidic detection chip. The driving device is also used to drive the first magnetic component to move laterally along an end face parallel to the microfluidic detection chip. The driving device is also used to drive a second magnetic component to move, such that the second magnetic component moves in a direction perpendicular to the microfluidic detection chip. The driving device is also used to drive the second magnetic component to move laterally along an end face parallel to the microfluidic detection chip.
[0037] Furthermore, the detection device includes a gas-driven control structure, which is used to draw or blow air into the docking hole in the microfluidic detection chip. The gas-driven control structure is also used to control the opening and closing of the docking hole.
[0038] As can be seen from the above technical solutions, the embodiments of this application have at least the following beneficial effects:
[0039] In the microfluidic detection chip, detection method, and detection device provided in this application embodiment, different reagents are injected into each liquid reagent chamber during operation, and the different liquid reagent chambers are separated by a reagent buffer chamber to prevent contamination caused by the mixing of different reagents. Magnetic particles are pre-set in the solid reagent chamber. After the magnetic particles flow into the liquid reagent chamber, they are dragged by an external magnetic field, causing them to pass through different liquid reagent chambers sequentially. This eliminates the need for complex mechanical disturbance structures, resulting in a simple structure for the entire microfluidic detection chip. During nucleic acid extraction, no other consumables (such as magnetic rod sleeves) are required, and substances such as lysis binding solution and washing solution that have already been transferred to the liquid reagent chamber do not need to be transferred across chambers. Therefore, no waste liquid is generated, and there is no need to set up a waste liquid chamber on the microfluidic chip. The dead volume during nucleic acid extraction is small, and the purity of the nucleic acid elution product is high. In addition, the reagents required for the reaction are pre-loaded on the detection chip in the form of a liquid capsule layer, eliminating the need for manual solution preparation, which simplifies the detection operation and further reduces the probability of reagent contamination. Attached Figure Description
[0040] To more clearly illustrate the technical solutions in the embodiments of this application or the prior art, the drawings used in the description of the embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of this application. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.
[0041] Figure 1 is a schematic diagram of the structure of a microfluidic detection chip provided in an embodiment of this application;
[0042] Figure 2 is an exploded view of the microfluidic detection chip provided in one embodiment of this application;
[0043] Figure 3 is a schematic diagram of the substrate structure in one embodiment of this application;
[0044] Figure 4 is a schematic diagram of the front side of the substrate in one embodiment of this application;
[0045] Figure 5 is a schematic diagram of the back side structure of the substrate in one embodiment of this application;
[0046] Figure 6 is a schematic diagram of the front side of the substrate in another embodiment of this application;
[0047] Figure 7 is a schematic diagram of the back side structure of the substrate in another embodiment of this application;
[0048] Figure 8 is a schematic diagram of the operation of the first magnetic component and the second magnetic component in one step of an embodiment of this application;
[0049] Figure 9 is a schematic diagram of the operation of the first magnetic component and the second magnetic component in one step of an embodiment of this application;
[0050] Figure 10 is a schematic diagram of the operation of the first magnetic component and the second magnetic component in one step of one embodiment of this application.
[0051] Reference numerals: 1. Magnetic particle; 2. First magnetic component; 3. Second magnetic component; 1100. Substrate; 1101. Sample cavity; 11011. First sample cavity aperture; 11012. Second sample cavity aperture; 11013. Third sample cavity aperture; 1102. Solid reagent cavity; 1103, Liquid-filled Buffer Chamber; 11031, First Liquid-filled Buffer Chamber; 11032, Second Liquid-filled Buffer Chamber; 11033, Third Liquid-filled Buffer Chamber; 11034, Fourth Liquid-filled Buffer Chamber; 11035, Fifth Liquid-filled Buffer Chamber; 1104, Liquid Reagent Chamber; 11041, First Reagent Chamber; 11042, Second Reagent Chamber; 11043, Third Reagent Chamber; 11044, Fourth Reagent Chamber; 11045, Fifth Reagent Chamber; 1105, Reagent Buffer Chamber; 11051, First Reagent Buffer Chamber; 11052, Second Reagent Buffer Chamber; 11053, Third Reagent Buffer Chamber; 11054, Fourth Reagent Buffer Chamber; 1106. Reaction chamber; 1107. Filtering chamber; 1108. Mixing chamber; 1109. Gas buffer chamber; 1110. Cavity; 1111. Mixing channel; 1112. First hydrophobic and breathable membrane chamber; 1113. Test paper receiving chamber; 1114. Second hydrophobic and breathable membrane chamber; 1115. Quantitative mixing chamber; 11151. Quantitative mixing chamber orifice; 1116. Third hydrophobic and breathable membrane chamber; 1200. Top sealing layer a; 1300. Bottom sealing layer; 1400. Top sealing layer b; 200. Puncture structure; 310. Liquid bladder unit; 320. Liquid bladder cover; 321. Through hole; 330. Adhesive layer; 410. First gas connection hole; 420. Air hole; 430. Second gas connection hole; 510, First shut-off valve; 520, Second shut-off valve; 530, Third shut-off valve; 540, Fourth shut-off valve. Detailed Implementation
[0052] The technical solutions of the embodiments of this application will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of this application, and not all embodiments. Based on the embodiments of this application, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of this application.
[0053] Referring to Figures 1 to 5, an embodiment of the first aspect of this application discloses a microfluidic detection chip, including a microfluidic layer, a puncture structure 200, and a liquid sac layer.
[0054] Specifically, the microfluidic layer includes a substrate 1100 and top and bottom sealing layers 1300 located on both sides of the substrate 1100. The substrate 1100 is provided with a sample chamber 1101, a solid reagent chamber 1102, a liquid buffer chamber 1103, a liquid reagent chamber 1104, a reagent buffer chamber 1105, and a reaction chamber 1106. The sample chamber 1101 is fluidly connected to the solid reagent chamber 1102 through a flow channel. There are multiple liquid buffer chambers 1103, and each liquid buffer chamber 1103 is independently arranged. The reagent chamber 1104 has multiple liquid reagent chambers 1104 arranged sequentially at intervals, and at least one reagent buffer chamber 1105 is arranged between two adjacent liquid reagent chambers 1104; each liquid buffer chamber 1103 is provided with a puncture structure 200; the liquid bladder layer is disposed on one side of the substrate 1100, and the liquid bladder layer includes multiple spaced and independent liquid bladder units 310, each liquid bladder unit 310 having a liquid bladder cavity, and each puncture structure 200 is opposite to the liquid bladder cavity of one of the liquid bladder units 310.
[0055] The first liquid reagent chamber 1104 at the front end is in fluid communication with the solid reagent chamber 1102, and the liquid reagent chamber 1104 at the end end is in fluid communication with the reaction chamber 1106. One of the liquid bladder buffer chambers 1103 is in fluid communication with one of the sample chamber 1101 and the first liquid reagent chamber 1104. Except for the first liquid reagent chamber 1104 at the front end, each of the remaining liquid reagent chambers 1104 is in fluid communication with a different liquid bladder buffer chamber 1103 through a flow channel.
[0056] It is understandable that multiple liquid reagent chambers 1104 are connected in sequence, and the end of the multiple liquid reagent chambers 1104 that is directly in fluid communication with the solid reagent chamber 1102 is the front end, and the other end is the end end.
[0057] In the microfluidic detection chip of this application embodiment, the number of liquid reagent chambers 1104 is set to be no less than 3.
[0058] In this embodiment, referring to Figure 4, there are five liquid reagent chambers 1104, namely, a first reagent chamber 11041, a second reagent chamber 11042, a third reagent chamber 11043, a fourth reagent chamber 11044, and a fifth reagent chamber 11045. The first reagent chamber 11041 is fluidly connected to the solid reagent chamber 1102 via a flow channel and is the first liquid reagent chamber 1104 located at the front end; the fifth reagent chamber 11045 is fluidly connected to the reaction chamber 1106 and is the liquid reagent chamber 1104 located at the end end.
[0059] In one embodiment of this application, the sample cavity 1101 is used to place a biological sample; the solid sample cavity 1101 is used to place magnetic particles 1, digestive enzymes (including but not limited to proteinase K, lysozyme, cell wall breaking enzyme, etc.), internal control materials, etc.; each liquid sac cavity of the liquid sac layer is used to pre-store various reagents required for detection, such as lysis binding solution, washing solution, elution solution, etc.; the reaction cavity 1106 is pre-stored with amplification reagents, etc.
[0060] During operation, the biological sample is placed in the sample chamber 1101, and the chamber cover of the sample chamber 1101 is closed; the liquid sac unit 310 connected to the sample chamber 1101 is squeezed to allow the reagent in the liquid sac chamber of the liquid sac unit 310 to flow into the sample chamber 1101 and mix with the biological sample; the mixed solution in the sample chamber 1101 is driven to flow into the solid reagent chamber 1102 to redissolve the substance preset in the solid reagent chamber 1102, thus obtaining a mixture; the mixture in the solid reagent chamber 1102 is driven into the first liquid reagent chamber 1104 and allowed to stand for a certain period of time; the first magnetic component 2 is controlled to... Near the top of the liquid reagent chamber 1104, the second magnetic element 3 is controlled to approach the bottom of the liquid reagent chamber 1104. Through the coordinated action of the first magnetic element 2 and the second magnetic element 3, the magnetic particles 1 in the reagent chamber are driven to pass through each liquid reagent chamber 1104 and the reagent buffer chamber 1105 in sequence, and the magnetic particles 1 are driven to finally move to the liquid reagent chamber 1104 at the end. The adsorption state of the magnetic particles 1 by the first magnetic element 2 and / or the second magnetic element 3 is maintained, and the elution products in the liquid reagent chamber 1104 at the end are driven into the reaction chamber 1106 for amplification reaction.
[0061] When the microfluidic detection chip is working, different reagents are injected into each liquid reagent chamber 1104, and the different liquid reagent chambers 1104 are separated by reagent buffer chambers 1105 to prevent contamination caused by the mixing of different reagents. Magnetic particles 1 are pre-installed in the solid reagent chamber 1102. After the magnetic particles 1 flow into the liquid reagent chambers 1104, they are dragged by an external magnetic field, causing them to pass through the different liquid reagent chambers 1104 sequentially. After passing through the reagent solutions in the different liquid reagent chambers 1104, the magnetic particles 1 are able to... Nucleic acid extraction is completed; no other consumables (such as magnetic rod sleeves) are required during the nucleic acid extraction process, and substances such as lysis binding solution and washing solution that have been transferred to the liquid reagent chamber 1104 do not need to be transferred across chambers, so no waste liquid is generated. There is no need to set up a waste liquid chamber on the microfluidic chip, the dead volume of the nucleic acid extraction process is small, the purity of the nucleic acid elution product is high, and the structure of the entire microfluidic detection chip is simple. In addition, the reagents required for the reaction are pre-loaded on the detection chip in the form of a liquid capsule layer and dried reagents, eliminating the need for manual liquid preparation, which simplifies the detection operation and further reduces the probability of reagent contamination.
[0062] In some embodiments of this application, referring to FIG4, the substrate 1100 is provided with a first gas connection hole 410 and a first shut-off valve 510. The first gas connection hole 410 is in fluid communication with the second liquid reagent chamber 1104 located at the front end, and the first shut-off valve 510 is used to control the opening and closing of the flow channel connected to the liquid inlet end of the reaction chamber 1106.
[0063] It is worth mentioning that in the scheme where the first gas connection hole 410 is in fluid communication with the second liquid reagent chamber 1104 located at the front end, the first gas connection hole 410 and the second liquid reagent chamber 1104 can be in direct fluid communication, or they can be indirectly connected through other flow channels or reagent buffer chambers.
[0064] In one possible implementation, the first gas docking port 410 is connected to the first reagent buffer chamber 11051 through the gas channel, and then connected to other liquid reagent chambers 1104 through the drag channel. The other liquid reagent chambers 1104 include the first reagent chamber 11041 to the fifth reagent chamber 11045.
[0065] Of course, in some other embodiments, the first gas docking hole 410 can also be directly connected to any one of the liquid reagent chamber 1104 and reagent buffer chamber 1105 through the gas channel, and connected to each other liquid reagent chamber 1104 and reagent buffer chamber 1105 through the drag channel, which is not limited here.
[0066] In practical applications, the gas pressure in each liquid reagent chamber 1104 can be controlled through the first gas connection port 410 and the first shut-off valve 510.
[0067] For example, in one possible application scenario, the gas-driven structure inside the detection device corresponding to the microfluidic detection chip connects to the first gas connection port 410, and simultaneously, the valve control structure inside the detection device controls the first shut-off valve 510, keeping it closed. Subsequently, the gas control structure inside the detection device extracts a certain volume of gas from the first gas connection port 410, creating a negative pressure state inside the liquid reagent chamber 1104. Under this negative pressure state, the mixture inside the sample chamber 1101 can be transferred to the first liquid reagent chamber 1104, i.e., the first reagent chamber 11041. At this time, a portion of the space inside the chip, such as the liquid reagent chamber 1104, is under negative pressure.
[0068] In some embodiments of this application, referring to Figures 3 and 4, the substrate 1100 is provided with a mixing channel 1111 and a mixing chamber 1108. One end of the mixing channel 1111 is in liquid communication with the liquid reagent chamber 1104 located at the end, and the other end of the mixing channel 1111 is in liquid communication with the inlet end of the mixing chamber 1108. The outlet end of the mixing chamber 1108 is in liquid communication with the inlet end of the first shut-off valve 510. After the elution product in the liquid reagent chamber 1104 at the end leaves the liquid reagent chamber 1104, it passes through the mixing channel 1111 and the mixing chamber 1108 in sequence, and then enters the reaction chamber 1106. The elution product is mixed during its passage through the mixing channel 1111 and then remixed in the mixing chamber 1108.
[0069] In one possible implementation, please continue to refer to Figures 3 and 4, where the mixing channel 1111 has a meandering course, which facilitates further mixing of the elution products.
[0070] In some embodiments of this application, referring to Figures 4 and 5, the substrate 1100 is provided with a test strip receiving cavity 1113, an air hole 420, a second shut-off valve 520, and a third shut-off valve 530. The test strip receiving cavity 1113 is in liquid communication with the liquid outlet of the reaction chamber 1106 through a flow channel, and the air hole 420 is in fluid communication with the liquid outlet of the reaction chamber 1106 through a flow channel. The second shut-off valve 520 is used to control the opening and closing of the flow channel between the liquid outlet of the reaction chamber 1106 and the air hole 420, and the third shut-off valve 530 is used to control the opening and closing of the flow channel between the test strip receiving cavity 1113 and the liquid outlet of the reaction chamber 1106.
[0071] Specifically, when it is necessary to expel the gas in the reaction chamber 1106, the second shut-off valve 520 is opened while the third shut-off valve 530 is closed, allowing the gas in the reaction chamber 1106 to be discharged through the vent 420. When it is necessary to allow the amplification product in the reaction chamber 1106 to flow to the test strip receiving chamber 1113, the second shut-off valve 520 is closed while the third shut-off valve 530 is opened, allowing the amplification product in the reaction chamber 1106 to flow to the test strip receiving chamber 1113 and come into contact with the chromatographic membrane strip disposed in the test strip receiving chamber 1113, thereby enabling the detection of the amplification product using the chromatographic membrane strip.
[0072] In some embodiments of this application, referring to Figures 6 and 7, the substrate 1100 is provided with a fourth shut-off valve 540, a quantitative mixing chamber 1115, and a second gas connection hole 430. The fourth shut-off valve 540 is disposed on a flow channel communicating with the liquid inlet end of the first shut-off valve 510. The quantitative mixing chamber hole 11151 of the quantitative mixing chamber 1115 is in fluid communication with the liquid outlet end of the fourth shut-off valve 540. The top of the quantitative mixing chamber 1115 is connected to the second gas connection hole 430 through a flow channel.
[0073] In one possible implementation, please continue to refer to Figures 6 and 7. The inlet end of the fourth shut-off valve 540 is fluidly connected to the outlet end of the mixing chamber 1108 through a flow channel, and the outlet end of the fourth shut-off valve 540 is fluidly connected to the inlet end of the first shut-off valve 510 through another flow channel. The quantitative mixing chamber orifice 11151 is connected to the flow channel between the outlet end of the fourth shut-off valve 540 and the inlet end of the first shut-off valve 510. A third hydrophobic and breathable membrane chamber 1116 is provided on the flow channel connecting the quantitative mixing chamber 1115 and the second gas docking hole 430.
[0074] In practical applications, the fourth shut-off valve 540 is opened and the first shut-off valve 510 is closed. The gas-driven control structure in the detection device is connected to the second gas docking port 430, and a certain amount of air is drawn into / drawn into the detection chip. This pushes the nucleic acid elution product in the liquid reagent chamber 1104 at the end through the mixing channel 1111, the mixing chamber 1108, and the fourth shut-off valve 540 in sequence, and enters the quantitative mixing chamber 1115 through the quantitative mixing chamber port 11151 to reconstitute the dry amplification reagent placed inside the quantitative mixing chamber 1115. At the same time, the gas in the quantitative mixing chamber 1115 can be discharged from the second gas docking port 430 through the hydrophobic and permeable membrane in the third hydrophobic and permeable membrane chamber 1116 via the channel. Subsequently, the fourth shut-off valve 540 is closed, the first shut-off valve 510 and the second shut-off valve 520 are opened, and the third shut-off valve 530 is closed; the gas-driven control structure inside the detection device is connected to the second gas docking hole 430, and a certain amount of air is injected into the second gas docking hole 430, pushing the reconstituted amplification reagent in the quantitative mixing chamber 1115 through the quantitative mixing chamber hole 11151, the first shut-off valve 510 and the reaction chamber 1106 in sequence, and filling the reaction chamber 1106 with the amplification reagent.
[0075] It is worth mentioning that, in addition to placing the dry amplification reagent in the quantitative mixing chamber 1115, a small ball that can be attracted by a magnetic component (such as a magnet) can also be placed inside. Under the influence of the external magnetic component, the small ball can move up and down inside the quantitative mixing chamber 1115, which can fully mix the reconstituted amplification reagent.
[0076] In some embodiments of this application, the reaction chamber 1106 is flat, and at least one cavity 1110 is provided on the outer periphery of the reaction chamber 1106. When the amplification reagent undergoes an amplification reaction within the reaction chamber 1106, the flat shape of the reaction chamber 1106 can improve heat conduction efficiency, which is beneficial to improving the efficiency of the amplification reaction. Simultaneously, the cavity 1110 on the outer periphery of the reaction chamber 1106 can block the heat conduction from the reaction chamber 1106 to the outside, which is beneficial to further improving the efficiency of the amplification reaction within the reaction chamber 1106.
[0077] It is worth understanding that the number of cavities 1110 can be set to multiple as needed; the shape of the cavities 1110 can be adapted to the shape of the reaction chamber 1106. For example, the shape of the cavities 1110 is arc-shaped, and the arc-shaped cavities 1110 are arranged around the reaction chamber 1106.
[0078] In some embodiments of this application, the number of reaction chambers 1106 is at least one. In practical applications, the number of reaction chambers 1106 can be set to multiple as needed, and multiple reaction chambers 1106 can be arranged in series or in parallel.
[0079] In some embodiments of this application, referring to Figures 1 and 3, the substrate 1100 includes a first portion and a second portion interconnected. The thickness of the second portion is less than the thickness of the first portion. A reaction chamber 1106 is disposed in the second portion, and the reaction chamber 1106 extends through the upper and lower end faces of the second portion. The upper end face of the second portion is sealed by a top sealing layer, and the lower end face is sealed by a bottom sealing layer 1300. The reaction chamber 1106 is defined by the top sealing layer, the chamber wall, and the bottom sealing layer 1300. The relatively small thickness of the top and bottom sealing layers 1300 further improves heat conduction efficiency, thereby increasing the amplification reaction rate.
[0080] It is worth mentioning that in the above embodiments, the top sealing layer includes a top sealing layer a1200 and a top sealing layer b1400, with the top sealing layer a1200 cooperating with the first part and the top sealing layer b1400 cooperating with the second part.
[0081] In some embodiments of this application, referring to FIG2, the liquid bladder unit 310 includes a liquid bladder shell and a liquid bladder sealing membrane. The liquid bladder shell forms a liquid bladder cavity with an opening, and the liquid bladder sealing membrane is disposed on the side of the liquid bladder cavity with the opening.
[0082] It is understandable that the liquid bladder shell is made of a soft material. Thus, the liquid bladder sealing membrane can be punctured by the puncture structure 200 by squeezing the liquid bladder shell, and the reagent pre-set in the liquid bladder cavity can flow from the liquid bladder cavity through the liquid bladder buffer cavity 1103 and the flow channel to the sample cavity 1101 or the liquid reagent cavity 1104.
[0083] In this embodiment, please continue to refer to Figure 2. The microfluidic detection chip includes an adhesive layer 330, which is disposed between the liquid bladder layer and the end face of the substrate 1100 where the puncture structure 200 is provided. The liquid bladder layer is fixedly connected to the substrate 1100 through the adhesive layer 330.
[0084] Furthermore, the microfluidic detection chip also includes a liquid bladder 320, which covers the outer periphery of the liquid bladder layer to prevent the liquid bladder layer from being accidentally squeezed. The liquid bladder 320 is connected to the substrate 1100 via a snap-fit structure. The liquid bladder 320 has a through hole 321 corresponding to the position of the liquid bladder unit 310, allowing the pressing structure of the detection device to pass through the through hole 321 and squeeze the liquid bladder unit 310.
[0085] An embodiment of the third aspect of this application discloses a detection device, comprising:
[0086] At least one pressure structure is used to squeeze each liquid bladder unit 310 of the liquid bladder layer respectively;
[0087] The magnetic assembly includes a first magnetic element 2 and a second magnetic element 3 arranged at intervals;
[0088] The driving device is used to drive the first magnetic element 2 to move so that the first magnetic element 2 moves in a direction perpendicular to the microfluidic detection chip. The driving device is also used to drive the first magnetic element 2 to move laterally in a direction parallel to the end face of the microfluidic detection chip. The driving device is used to drive the second magnetic element 3 to move so that the second magnetic element 3 moves in a direction perpendicular to the microfluidic detection chip. The driving device is also used to drive the second magnetic element 3 to move laterally in a direction parallel to the end face of the microfluidic detection chip.
[0089] In some embodiments of this application, the detection device drives the first magnetic element 2 and the second magnetic element 3 to move synchronously through a driving device, so as to drag the magnetic particle 1 to move between different positions in the reagent chamber liquid reagent chamber 1104, or to drag the magnetic particle 1 to transfer between different liquid reagent chambers 1104.
[0090] In one possible implementation, the driving device includes a U-shaped bracket, with a first magnetic element 2 connected to one end of the U-shaped bracket and a second magnetic element 3 connected to the other end of the U-shaped bracket. The microfluidic detection chip is located between the first magnetic element 2 and the second magnetic element 3. The driving device can drive the first magnetic element 2 and the second magnetic element 3 to move laterally synchronously by moving the U-shaped bracket laterally. By moving the U-shaped bracket along the line connecting the first magnetic element 2 and the second magnetic element 3, the first magnetic element 2 can be moved away from the microfluidic detection chip while the second magnetic element 3 moves closer to the microfluidic detection chip, or the first magnetic element 2 can be moved closer to the microfluidic detection chip while the second magnetic element 3 moves away from the microfluidic detection chip. The line connecting the first magnetic element 2 and the second magnetic element 3 is perpendicular to the microfluidic detection chip.
[0091] In some other embodiments, there can be two driving devices, namely a first driving device and a second driving device. The first driving device is used to drive the first magnetic component 2 to move independently, and the second driving device is used to drive the second magnetic component 3 to move independently. For example, the first driving device is used to drive the first magnetic component 2 to move so that the first magnetic component 2 moves in a direction perpendicular to the microfluidic detection chip. The driving device is also used to drive the first magnetic component 2 to move laterally in a direction parallel to the end face of the microfluidic detection chip so as to drive the magnetic particle 1 to move laterally.
[0092] In one embodiment, the supporting detection equipment includes a gas-driven control mechanism, which is used to draw in or blow air into the gas docking hole. The gas-driven control mechanism is also used to control the opening and closing of the gas docking hole so that the gas docking hole can be connected to the external atmospheric environment, thereby balancing the gas pressure inside and outside the chip.
[0093] The gas connection hole can be either a first gas connection hole 410 or a second gas connection hole 420.
[0094] The microfluidic detection chip, detection method, and detection device of this application are described in detail below with specific embodiments. It should be understood that the following embodiments are merely illustrative and should not be construed as limiting the embodiments of this application.
[0095] In this embodiment, referring to Figures 1 to 5, the liquid bladder buffer chamber 1103 includes a first liquid bladder buffer chamber 11031, a second liquid bladder buffer chamber 11032, a third liquid bladder buffer chamber 11033, a fourth liquid bladder buffer chamber 11034, and a fifth liquid bladder buffer chamber 11035. The liquid reagent chamber 1104 includes a first reagent chamber 11041, a second reagent chamber 11042, a third reagent chamber 11043, a fourth reagent chamber 11044, and a fifth reagent chamber 11045. A mixing channel 1111 and a mixing chamber 1108 are sequentially connected between the fifth reagent chamber 11045 and the reaction chamber 1106. A first shut-off valve 510 is provided between the liquid outlet of the mixing chamber 1108 and the liquid inlet of the reaction chamber 1106.
[0096] The working principle of the detection chip in the detection equipment is as follows:
[0097] The internal pressure structure of the detection device compresses the top of the liquid bladder unit 310 corresponding to the first liquid bladder buffer chamber 11031 through the through hole 321 on the liquid bladder cover 320. The liquid bladder sealing membrane below the liquid bladder unit 310 is punctured by the puncture structure 200, and the liquid reagent in the liquid bladder cavity can flow out from the liquid bladder cavity to the first liquid bladder buffer chamber 11031, and then flow out through the liquid outlet hole of the first liquid bladder buffer chamber 11031, and enter the sample chamber 1101 through the flow channel through the first sample chamber hole 11011. Similarly, other pressure structures inside the detection device compress other liquid bladder units 310 respectively, so that the liquid reagent in the liquid bladder cavity of each liquid bladder unit 310 flows into the second reagent chamber 11042, the third reagent chamber 11043, the fourth reagent chamber 11044 and the fifth reagent chamber 11045.
[0098] The sample chamber 1101 is connected to the filter chamber 1107 through the second sample chamber hole 11012 and the flow channel. A filter membrane is provided in the filter chamber 1107. The filter membrane can be tightly attached to the bottom wall of the filter chamber 1107 through the filter membrane bonding surface. A top sealing layer a1200 is covered on the top of the filter membrane, and there is a certain distance between the filter membrane and the top sealing layer a1200, thereby forming a cavity 1110. The filter chamber 1107 is in fluid communication with the solid reagent chamber 1102 through the filter chamber outlet flow channel.
[0099] Solid reagents can be placed in the solid reagent chamber 1102, and the solid reagents are preferably prepared by freeze-drying. The bottom of the solid reagent chamber 1102 preferably adopts a downward concave structure to facilitate the discharge of reagents or magnetic particles 1 from the solid reagent chamber 1102. A solid reagent chamber hole is provided in the middle of the bottom of the solid reagent chamber 1102, and the solid reagent chamber hole is located at the lowest position of the bottom of the solid reagent chamber 1102.
[0100] The solid reagent chamber orifice is connected to the liquid inlet of the first reagent chamber 11041 through a flow channel. The liquid inlet can be located at the bottom of the first reagent chamber 11041, or the liquid inlet can be located above the bottom of the first reagent chamber 11041 through a columnar flow channel.
[0101] Specifically, a first reagent buffer chamber 11051 is provided between the first reagent chamber 11041 and the second reagent chamber 11042, a second reagent buffer chamber 11052 is provided between the second reagent chamber 11042 and the third reagent chamber 11043, a third reagent buffer chamber 11053 is provided between the third reagent chamber 11043 and the fourth reagent chamber 11044, and a fourth reagent buffer chamber 11054 is provided between the fourth reagent chamber 11044 and the fifth reagent chamber 11045.
[0102] In the microfluidic detection chip of this embodiment, one or more reagent buffer chambers 1105 can be set between two adjacent liquid reagent chambers 1104. Liquid overflowing from each liquid reagent chamber 1104 can enter the reagent buffer chamber 1105, thus avoiding the mixing of liquid reagents in different liquid reagent chambers 1104.
[0103] Different liquid reagent chambers 1104 and reagent buffer chambers 1105 are connected by a drag channel, which is configured to allow magnetic particles 1 near the top sealing layer a1200 to pass through.
[0104] The external magnetic field attracts the magnetic particles 1 in the liquid reagent chamber 1104 from top to bottom, which can make the magnetic particles 1 fully mixed with the liquid reagent chamber 1104. By dragging the magnetic particles 1 laterally by the external magnetic field, the magnetic particles 1 can be transferred between different liquid reagent chambers 1104 and reagent buffer chambers 1105.
[0105] After the magnetic particle 1 is transferred to the fifth reagent chamber 11045, the elution product in the fifth reagent chamber 11045 is fluidly connected to the mixing channel 1111 through the liquid outlet and the flow channel. The mixing channel 1111 is fluidly connected to the mixing chamber 1108. The mixing chamber 1108 is fluidly connected to the liquid inlet of the first shut-off valve 510 through the flow channel. The liquid outlet of the first shut-off valve 510 is fluidly connected to the liquid inlet of the reaction chamber 1106 through the flow channel.
[0106] The reaction chamber 1106 has a flat structure and several cavities 1110 are arranged around it. The cavities 1110 penetrate the microfluidic layer. The upper part of the reaction chamber 1106 is covered by a top sealing layer b1400 and the lower part is covered by a bottom sealing layer 1300. The plane of the top sealing layer b1400 is located between the top sealing layer a1200 and the bottom sealing layer 1300.
[0107] The liquid outlet of the reaction chamber 1106 is connected to one end of another flow channel. The other end of the flow channel is provided with a branch channel a and a branch channel b. A second shut-off valve 520 is provided between the branch channel a and the second gas docking hole 430.
[0108] Furthermore, a second hydrophobic and breathable membrane cavity 1114 is provided between the second shut-off valve 520 and the vent 420. The second hydrophobic and breathable membrane is disposed within the second hydrophobic and breathable membrane cavity 1114 and is tightly attached to the bottom microfluidic layer surface of the second hydrophobic and breathable membrane cavity 1114. In this embodiment, the hydrophobic and breathable membrane used in the microfluidic detection chip allows gas to pass through but blocks liquid from passing through. A third shut-off valve 530 is provided between the branch channel b and the test strip receiving cavity 1113. The opening side of the test strip cavity is covered by a bottom sealing layer 1300; several support and positioning structures are provided inside the test strip cavity for placing and fixing the chromatography membrane strip, as shown in Figures 5 and 7.
[0109] In this embodiment, the flow of some liquid inside the microfluidic detection chip is driven by gas. Specifically, the first hole on the sealing layer a1200 at the top of the detection chip corresponds to the first gas docking hole 410. The first hole is used to dock with the gas-driven structure inside the detection device. External gas can enter the first reagent buffer chamber 1105 and the second reagent chamber 11042 through the first hydrophobic and breathable membrane in the first hydrophobic and breathable membrane chamber 1112 through the first gas docking hole 410, and then connect to other liquid reagent chambers 1104 and reagent buffer chambers 1105 (such as the first reagent chamber 11041, the third reagent chamber 11043, the second reagent buffer chamber 11052, the third reagent buffer chamber 11053, etc.) via the drag channel.
[0110] In addition, to buffer the internal gas pressure during the operation of the microfluidic detection chip, several gas buffer chambers 1109 are provided inside the detection chip, and the gas buffer chambers 1109 are connected to each other through gas channels. Specifically, the sample chamber 1101 has a third sample chamber orifice 11013, one end of which is connected to a columnar flow channel. The end of the columnar flow channel is higher than the liquid level of the sample solution in the sample chamber 1101. In this way, the sample chamber 1101 can be fluidly connected to the gas buffer chambers 1109 through the columnar flow channel, the third sample chamber orifice 11013, and the gas channel, as shown in Figure 4.
[0111] An embodiment of the second aspect of this application discloses a detection method applied to the microfluidic detection chip as described above, the method comprising the following steps:
[0112] Place the biological sample into sample chamber 1101 and close sample chamber 1101;
[0113] The liquid sac unit 310, which is connected to the sample cavity 1101, is squeezed to allow the reagent in the liquid sac unit 310 to flow into the sample cavity 1101 and mix with the biological sample to obtain a mixed solution.
[0114] The mixed solution is driven to flow into the solid reagent chamber 1102 to redissolve the substance in the solid reagent chamber 1102 to obtain a mixture, wherein magnetic particles 1 are pre-set in the solid reagent chamber 1102.
[0115] The mixture in the solid reagent chamber 1102 is driven into the first liquid reagent chamber 1104 and allowed to stand;
[0116] The magnetic component is controlled to approach the top and / or bottom of the liquid reagent chamber 1104, and the magnetic component is used to drive the magnetic particles 1 in the liquid reagent chamber 1104 to pass through each liquid reagent chamber 1104 and the reagent buffer chamber 1105 in sequence, and drive the magnetic particles 1 to finally move to the end liquid reagent chamber 1104.
[0117] Maintaining the magnetic adsorption state of the magnetic particles 1 by the magnetic component, the elution product in the liquid reagent chamber 1104 at the end is driven into the reaction chamber 1106 to carry out the amplification reaction.
[0118] In some embodiments of this application, gas can be repeatedly drawn into the microfluidic detection chip through the first gas docking hole 410, so that the liquid inside the first liquid reagent chamber 1104 flows back and forth between the sample chamber 1101 and the solid reagent chamber 1102 to achieve mixing; then, gas is drawn into the microfluidic detection chip through the first gas docking hole 410, so that all the liquid enters the first liquid reagent chamber 1104, and then it is allowed to stand.
[0119] The microfluidic chip of this application embodiment can be combined with in vitro diagnostic reagents and technologies to develop a variety of rapid detection technologies, including but not limited to microfluidic-based colloidal gold detection technology, immunofluorescence detection technology, chemiluminescence technology, and microfluidic-based nucleic acid detection technology.
[0120] The microfluidic detection chip, detection method, and detection device of this application are described in detail below with specific embodiments. It should be noted that the following embodiments are merely illustrative and should not be construed as limiting the embodiments of this application.
[0121] Example 1:
[0122] In Example 1, a chromatographic membrane strip is used to detect nucleic acid amplification products. The solid reagent chamber 1102 of the microfluidic detection chip is pre-loaded with lyophilized magnetic particles 1, digestive enzymes (including but not limited to proteinase K, lysozyme, cell-wall-breaking enzymes, etc.), internal control materials, etc. The liquid capsule unit 310 includes a first liquid capsule unit, a second liquid capsule unit, a third liquid capsule unit, a fourth liquid capsule unit, and a fifth liquid capsule unit. The liquid capsule chamber of the first liquid capsule unit is pre-loaded with lysis binding solution, the liquid capsule chamber of the second liquid capsule unit is pre-loaded with washing solution 1, the liquid capsule chamber of the third liquid capsule unit is pre-loaded with washing solution 2, the liquid capsule chamber of the fourth liquid capsule unit is pre-loaded with washing solution 3, and the liquid capsule chamber of the fifth liquid capsule unit is pre-loaded with elution solution. Amplification reagents (PCR reagents, isothermal amplification reagents, etc.) are pre-placed in the reaction chamber 1106 in a dried form (including but not limited to lyophilized form, air-dried form, etc.). The test strip receiving chamber 1113 contains a chromatographic membrane strip for nucleic acid detection.
[0123] Step 1: Add a certain volume of biological sample (including but not limited to blood sample, respiratory sample, urine sample, fecal sample, cell culture, etc.) to the sample chamber 1101 of the microfluidic detection chip, close the chamber cover of the sample chamber 1101, insert the microfluidic detection chip into the detection device, and the detection device will start to run according to the set program.
[0124] Step 2: The internal pressure structure of the detection device will squeeze the first liquid bladder unit downwards. The sealing membrane of the liquid bladder at the bottom of the first liquid bladder unit will be punctured by the structure 200. Under the continuous downward pressure of the pressure structure, the lysis binding fluid inside will be released. After the pressure structure is completed, it will maintain its final position. At the same time, the lysis binding fluid will enter the sample chamber 1101 through the outlet hole at the bottom of the liquid bladder buffer chamber 1103 and through the flow channel. Then, the lysis binding fluid will form a mixture with the biological sample in the sample chamber 1101. Due to the positive pressure in the sample chamber 1101, the mixture in the sample chamber 1101 will flow out from the second sample chamber hole 11012. After being filtered by the filter membrane of the filter chamber 1107, it will enter the solid reagent chamber 1102 and re-dissolve the magnetic particles 1, digestive enzymes and other substances pre-loaded in the solid reagent chamber 1102. Then, the mixture in the solid reagent chamber 1102 will flow into the first reagent chamber 11041 through the flow channel.
[0125] Step 3: At this time, the gas drive structure inside the detection device connects with the first gas docking hole 410 on the detection chip, and at the same time, the valve control structure inside the detection device controls the first shut-off valve 510 to close the first shut-off valve 510. At this time, the flow channel between the liquid inlet end of the reaction chamber 1106 and the mixing chamber 1108 is cut off by the first shut-off valve 510.
[0126] Step 4: The gas control structure inside the detection device draws a certain amount of gas from the first gas docking hole 410, so that each liquid reagent chamber 1104 is in a negative pressure state. Due to the pressure difference, the mixture inside the sample chamber 1101 can be transferred to the first reagent chamber 11041. At this time, some spaces inside the chip, such as the liquid reagent chamber 1104, will be in a negative pressure state.
[0127] Step 5: Maintain a negative pressure state and allow the mixture of biological sample, lysis binding solution, magnetic particles 1, and digestive enzyme to stand and incubate in the first reagent chamber 11041 for a certain period of time. The incubation process can be carried out by using equipment for heat incubation.
[0128] Step 6: An external magnetic field is applied by the detection device above the top sealing layer a1200 above the first reagent chamber 11041 and below the bottom sealing layer 1300 below the first reagent chamber 11041. The external magnetic field can be an electromagnet or a permanent magnet. In this embodiment, a permanent magnet is preferred. The detection device moves the top magnet and the bottom magnet to positions above and below the first reagent chamber 11041.
[0129] Step 7: The top magnet moves downwards towards the top sealing layer a1200 of the first reagent chamber 11041 to attract the magnetic particles 1 inside the first reagent chamber 11041 until the magnetic particles 1 are attracted and gathered on the side of the top sealing layer located inside the first reagent chamber 11041.
[0130] Step 8: At this time, the top magnet moves upward away from the top sealing layer a1200 of the first reagent chamber 11041, while the bottom magnet moves upward towards the bottom sealing layer 1300 of the reagent chamber 1, so as to attract the magnetic particles 1 from the top sealing layer downward to the bottom of the reagent chamber 1.
[0131] Step 9: Steps 7 and 8 can be repeated several times;
[0132] Step 10: The bottom magnet moves away from the bottom of the first reagent chamber 11041, and the top magnet moves close to the top of the first reagent chamber 11041, attracting the magnetic particles 1 in the first reagent chamber 11041 to the side of the top sealing layer a located inside the first reagent chamber 11041.
[0133] Step 11: The gas control structure inside the detection device that is connected to the first gas connection hole 410 releases the negative pressure inside the chip, so that the gas pressure inside the microfluidic detection chip is consistent with the external ambient gas pressure and maintains a gas pressure balance.
[0134] Step 12: The detection device sequentially squeezes the fifth liquid bladder unit, the fourth liquid bladder unit, the third liquid bladder unit, and the second liquid bladder unit, transferring the pre-filled eluent, cleaning solution 3, cleaning solution 2, and cleaning solution 1 inside through the corresponding flow channels to the fifth reagent chamber 11045, the fourth reagent chamber 11044, the third reagent chamber 11043, and the second reagent chamber 11042, while maintaining the final position of each pressing structure;
[0135] Step 13: Move the top magnet horizontally and move the bottom magnet simultaneously to transfer the magnetic particle 1 through the drag channel to the first reagent buffer chamber 11051, and continue dragging it through the push channel to the top sealing layer a1200 located on the side of the second reagent chamber 11042 above the second reagent chamber 11042.
[0136] Step 14: Move the bottom magnet upwards towards the bottom sealing layer 1300 below the second reagent chamber 11042, while moving the top magnet upwards away from the top sealing layer a1200, so that the magnetic particles 1 are attracted to the bottom of the second reagent chamber 11042.
[0137] Step 15: At this time, the top magnet moves downwards towards the top sealing layer a1200 of the second reagent chamber 11042, while the bottom magnet moves away from the bottom sealing layer 1300 below the second reagent chamber 11042, attracting the magnetic particles 1 to the top sealing layer a1200 above the second reagent chamber 11042, located on the side inside the second reagent chamber 11042.
[0138] Step 16: Repeat steps 14 and 15 several times; or move the top magnet laterally to other positions on the top sealing layer a1200 above the second reagent chamber 11042 and repeat steps 14 and 15 several times to ensure that the magnetic particles 1 are thoroughly cleaned in different areas of the cleaning solution 2 in the second reagent chamber 11042 to remove impurities.
[0139] Step 17: Following the above method, drag the magnetic particles 1 sequentially to the third reagent chamber 11043 (inside which cleaning solution 2 has been injected) and the fourth reagent chamber 11044 (inside which cleaning solution 3 has been injected), and clean them sequentially. During this process, the magnetic particles 1 will successively pass through the third dragging channel, the second reagent buffer chamber 11052, the fourth dragging channel, the third reagent chamber 11043, the fifth dragging channel, the third reagent buffer chamber 11053, the sixth dragging channel, and the fourth reagent chamber 11044;
[0140] Step 18: Finally, drag magnetic particle 1 to the fifth reagent chamber 11045, and then, following the up-and-down and lateral movement of the magnet as described in steps 14, 15, and 16, release the nucleic acid adsorbed on the surface of magnetic particle 1 into the elution buffer, thereby obtaining the nucleic acid elution product. During the elution process, auxiliary equipment can also be selected for heat incubation of the elution process.
[0141] It is worth mentioning that the process of magnets adsorbing and dragging in steps 6 to 18 is shown in Figures 8 to 10.
[0142] Step 19: Maintain the adsorption state of the magnetic particles 1 in the reagent chamber by the magnet at the top of the fifth reagent chamber 11045, open the first shut-off valve 510, and close the third shut-off valve 530.
[0143] Step 20: The gas-driven control structure inside the detection device is connected to the first gas connection hole 410, and a certain amount of air is injected into the chip to push the liquid nucleic acid elution product in the fifth reagent chamber 11045 through the mixing channel 1111, the mixing chamber 1108, the first shut-off valve 510 and the reaction chamber 1106, and fill the reaction chamber 1106. The reaction chamber 1106 is pre-filled with dry amplification reagents.
[0144] Step 21: Close the first shut-off valve 510 and the second shut-off valve 520. With the support of the detection equipment, the amplification reaction takes place inside the reaction chamber 1106;
[0145] Step 22: After the amplification reaction is completed, open the first stop valve 510 and the third stop valve 530, connect the gas drive control structure in the detection device to the first gas connection hole 410, and inject a certain amount of air into the microfluidic detection chip so that the amplification product in the reaction chamber 1106 enters the test strip receiving chamber 1113 through the flow channel and the third stop valve 530 for chromatography detection.
[0146] Step 23: During the chromatography detection process, the third shut-off valve 530 can be closed, or the positive pressure state in each flow channel inside the detection chip connected to the first gas docking port 410 can be maintained. Alternatively, according to the detection needs, a corresponding heating device can be set in the detection equipment to heat the test strip receiving cavity 1113 to maintain a certain range of chromatography temperature inside the cavity, making the chromatography detection more accurate.
[0147] Step 24: After the chromatography detection is completed, the internal structure of the detection equipment is reset, and the microfluidic detection chip is removed.
[0148] Example 2:
[0149] In Example 2, real-time fluorescence was used to detect the amplification results. The solid reagent chamber 1102 of the microfluidic detection chip is pre-loaded with lyophilized magnetic particles 1, digestive enzymes (including but not limited to proteinase K, lysozyme, cell-wall-breaking enzymes, etc.), and internal control materials. The liquid capsule unit 310 includes a first liquid capsule unit, a second liquid capsule unit, a third liquid capsule unit, a fourth liquid capsule unit, and a fifth liquid capsule unit. The liquid capsule chamber of the first liquid capsule unit is pre-loaded with lysis binding solution, the liquid capsule chamber of the second liquid capsule unit is pre-loaded with washing solution 1, the liquid capsule chamber of the third liquid capsule unit is pre-loaded with washing solution 2, the liquid capsule chamber of the fourth liquid capsule unit is pre-loaded with washing solution 3, and the liquid capsule chamber of the fifth liquid capsule unit is pre-loaded with elution solution. Amplification reagents (fluorescent PCR reagents, fluorescent isothermal amplification reagents, etc.) are pre-placed in the reaction chamber 1106 in a dried form (including but not limited to lyophilized form, air-dried form, etc.). No chromatography membrane strip is placed in the test strip receiving chamber 1113.
[0150] The specific steps of the test are as follows:
[0151] Step 1: Add a certain volume of biological sample (including but not limited to blood sample, respiratory sample, urine sample, fecal sample, cell culture, etc.) to the sample chamber 1101 of the microfluidic detection chip, close the chamber cover of the sample chamber 1101, insert the microfluidic detection chip into the detection device, and the device will start to run according to the set program.
[0152] Step 2: The internal pressure structure of the device will squeeze the first liquid bladder unit downwards, and the sealing membrane of the liquid bladder at the bottom of the first liquid bladder unit will be punctured by the structure 200. Under the continuous downward pressure of the pressure structure, the internal lysis binding fluid will be released, and the pressure structure will maintain its final position. At the same time, the lysis binding fluid will enter the sample chamber 1101 through the outlet hole at the bottom of the first liquid bladder buffer chamber 11031 and flow through the channel, forming a mixture with the biological sample in the sample chamber 1101. Due to the positive pressure in the sample chamber 1101, the mixture in the sample chamber 1101 will flow out from the second sample chamber hole 11012, and after being filtered by the filter membrane of the filter chamber 1107, it will enter the solid reagent chamber 1102, and re-dissolve the magnetic particles 1, digestive enzymes and other substances pre-loaded in the solid reagent chamber 1102. Then the mixture in the solid reagent chamber 1102 will flow into the first reagent chamber 11041.
[0153] Step 3: At this time, the gas driving structure inside the detection device connects with the first gas docking hole 410 on the detection chip, and at the same time, the valve control structure inside the device controls the first shut-off valve 510 to keep the first shut-off valve 510 closed; Step 4: The gas control structure inside the detection device draws a certain amount of gas from the first gas docking hole 410 of the microfluidic chip, so that all the mixture inside the sample chamber 1101 is transferred to the first reagent chamber 11041. At this time, some spaces inside the detection chip, such as the liquid reagent chamber 1104, will be under negative pressure.
[0154] Step 5: Maintain a negative pressure state and allow the mixture of biological sample, lysis binding solution, magnetic particles 1, and digestive enzyme to stand and incubate in the first reagent chamber 11041 for a certain period of time. The incubation process can be carried out by using equipment for heat incubation.
[0155] Step 6: Then, the detection device applies an external magnetic field above the top sealing layer a1200 above the first reagent chamber 11041 and below the bottom sealing layer 1300 below the first reagent chamber 11041. The external magnetic field can be an electromagnet or a permanent magnet. In this embodiment, a permanent magnet is preferred. The detection device moves the top magnet and the bottom magnet to positions above and below the first reagent chamber 11041.
[0156] Step 7: The top magnet moves downwards towards the top sealing layer a1200 of the first reagent chamber 11041 to attract magnetic particles 1 until the magnetic particles 1 are attracted and gathered on the side of the top sealing layer a1200 located inside the first reagent chamber 11041.
[0157] Step 8: At this time, the top magnet moves upward away from the top sealing layer a1200 of the first reagent chamber 11041, while the bottom magnet moves upward towards the bottom sealing layer 1300 of the first reagent chamber 11041, attracting the magnetic particles 1 from the top sealing layer a1200 downward to the bottom of the first reagent chamber 11041.
[0158] Step 9: Steps 7 and 8 can be repeated several times;
[0159] Step 10: The bottom magnet moves away from the bottom of the first reagent chamber 11041, and the top magnet moves close to the top of the first reagent chamber 11041, attracting the magnetic particles 1 in the first reagent chamber 11041 to the side of the top sealing layer a1200 located inside the first reagent chamber 11041.
[0160] Step 11: The gas control structure inside the detection device that is connected to the first gas connection hole 410 releases the negative pressure inside the chip, so that the gas pressure inside the microfluidic detection chip is consistent with the external ambient gas pressure and maintains a gas pressure balance.
[0161] Step 12: The detection device sequentially squeezes the fifth liquid bladder unit, the fourth liquid bladder unit, the third liquid bladder unit, and the second liquid bladder unit, transferring the pre-filled eluent, cleaning solution 3, cleaning solution 2, and cleaning solution 1 through the corresponding flow channels to the fifth reagent chamber 11045, the fourth reagent chamber 11044, the third reagent chamber 11043, and the second reagent chamber 11042, while maintaining the final position of the pressing structure.
[0162] Step 13: Move the top magnet horizontally and move the bottom magnet simultaneously to transfer the magnetic particle 1 through the drag channel 1 to the first reagent buffer chamber 11051, and continue dragging it through the second push channel to transfer it to the top sealing layer above the second reagent chamber 11042 on one side inside the second reagent chamber 11042.
[0163] Step 14: Move the bottom magnet upwards towards the bottom sealing layer 1300 below the second reagent chamber 11042, while moving the top magnet upwards away from the top sealing layer a1200, so that the magnetic particles 1 are attracted to the bottom of the second reagent chamber 11042.
[0164] Step 15: At this time, the top magnet moves downwards towards the top sealing layer a1200 of the second reagent chamber 11042, while the bottom magnet moves away from the bottom sealing layer 1300 below the second reagent chamber 11042, attracting the magnetic particles 1 to the top sealing layer a1200 above the second reagent chamber 11042, located on the side inside the second reagent chamber 11042.
[0165] Step 16: Repeat steps 14 and 15 several times; or move the top magnet laterally to other positions on the top sealing layer a1200 above the second reagent chamber 11042 and repeat steps 14 and 15 several times to allow the magnetic particles 1 to be thoroughly cleaned in different areas of the cleaning solution 2 to remove impurities.
[0166] Step 17: Following the method described above, drag the magnetic particles 1 sequentially to the third reagent chamber 11043 (inside which cleaning solution 2 has been injected) and the fourth reagent chamber 11044 (inside which cleaning solution 3 has been injected), and clean them sequentially. During this process, the magnetic particles 1 will successively pass through the third dragging channel, the second reagent buffer chamber 11052, the fourth dragging channel, the third reagent chamber 11043, the fifth dragging channel, the third reagent buffer chamber 11053, the sixth dragging channel, and the fourth reagent chamber 11044.
[0167] Step 18: Finally, drag the magnetic particle 1 to the fifth reagent chamber 11045, and then, following the up-and-down and lateral movement of the magnet as described in steps 14, 15, and 16, release the nucleic acid adsorbed on the surface of the magnetic particle 1 in the elution buffer to obtain the nucleic acid elution product. During the elution process, auxiliary equipment can also be selected for heat incubation of the elution process. During this period, the magnetic particle 1 will successively pass through the seventh dragging channel, the fourth reagent buffer chamber 11054, and then enter the fifth reagent chamber 11045; it is worth mentioning that the up-and-down adsorption and dragging process of the magnet in steps 6 to 18 is shown in Figures 8 to 10;
[0168] Step 19: Maintain the adsorption state of the magnetic particles 1 in the reagent chamber by the magnet at the top of the fifth reagent chamber 11045, open the first shut-off valve 510, and close the third shut-off valve 530.
[0169] Step 20: The gas-driven control structure inside the detection device is connected to the first gas connection hole 410, and a certain amount of air is injected into the chip to push the liquid nucleic acid elution product in the fifth reagent chamber 11045 through the mixing channel 1111, the mixing chamber 1108, and the first shut-off valve 510 in sequence, and then enter the reaction chamber 1106 and fill the reaction chamber 1106. The reaction chamber 1106 is pre-filled with dry amplification reagents.
[0170] Step 21: Close the first shut-off valve 510 and the second shut-off valve 520. With the support of the detection equipment, the amplification reaction takes place inside the reaction chamber 1106, and the detection equipment performs real-time fluorescence detection.
[0171] Step 22: The test is completed. The internal structure of the test equipment is reset, and the microfluidic test chip is removed.
[0172] Example 3:
[0173] In Example 3, referring to Figures 6 and 7, in order to ensure that the dried amplification reagent is fully reconstituted and mixed, a quantitative mixing chamber 1115 and its auxiliary structure are added to the microfluidic detection chip. This can better ensure the quantitative reconstitution and full mixing of the amplification reagent, improve the reconstitution accuracy and reaction efficiency of the detection reagent, and inject the amplification reagent into the reaction chamber 1106 for amplification reaction after it is reconstituted and mixed in the quantitative mixing chamber 1115.
[0174] Please refer to Figures 6 and 7. The substrate 1100 is provided with a quantitative mixing chamber 1115 and its auxiliary structures. Specifically, the fifth reagent chamber 11045 is connected to the mixing channel 1111 via an outlet and a flow channel. The mixing channel 1111 is connected to the mixing chamber 1108. The outlet end of the mixing chamber 1108 is fluidly connected to the input end of the fourth shut-off valve 540 via a flow channel. The output end of the fourth shut-off valve 540 is fluidly connected to the input end of the first shut-off valve 510 via a flow channel. Simultaneously, the mixing chamber orifice of the quantitative mixing chamber 1115 and the flow channel between the fourth shut-off valve 540 and the first shut-off valve 510 are fluidly connected. The bottom of the quantitative mixing chamber 1115 is preferably designed as a downwardly recessed structure, with the quantitative mixing chamber orifice 11151 located at the lowest point of the bottom of the quantitative mixing chamber 1115. The top of the quantitative mixing chamber 1115 is connected to the third hydrophobic and breathable membrane chamber 1116 via a flow channel. The third hydrophobic and breathable membrane chamber 1116 contains a third hydrophobic and breathable membrane tightly fitted within it. Gas within the third hydrophobic and breathable membrane chamber 1116 passes through the hydrophobic and breathable membrane and then communicates with the second gas connection hole 430 via a gas channel. Additionally, the bottom sealing layer 1300 is provided with holes 3 corresponding to the second gas connection hole 430.
[0175] In Example 3, a chromatographic membrane strip was used to detect nucleic acid amplification products. The microfluidic detection chip's solid reagent chamber 1102 is pre-loaded with lyophilized magnetic particles 1, digestive enzymes (including but not limited to proteinase K, lysozyme, and cell-wall-breaking enzymes), and internal control materials. The first liquid-filled unit is pre-loaded with lysis binding solution, the second liquid-filled unit with washing solution 1, the third liquid-filled unit with washing solution 2, the fourth liquid-filled unit with washing solution 3, and the fifth liquid-filled unit with elution solution. Amplification reagents (PCR reagents, isothermal amplification reagents, etc.) are pre-placed in the reaction chamber 1106 in a dried form (including but not limited to lyophilized or air-dried forms). The test strip receiving chamber 1113 contains a chromatographic membrane strip for nucleic acid detection. With the addition of a quantitative mixing chamber 1115 and its auxiliary structures, the detection steps of the microfluidic detection chip are as follows:
[0176] Step 1: Add a certain volume of biological sample (including but not limited to blood sample, respiratory sample, urine sample, fecal sample, cell culture, etc.) to the sample chamber 1101 of the microfluidic detection chip, close the chamber cover of sample chamber 1101, insert the detection chip into the detection device, and the device will start running according to the set program.
[0177] Step 2: The internal pressure structure of the device will squeeze the first liquid bladder unit downwards, and the sealing membrane of the liquid bladder under the first liquid bladder unit will be punctured by the puncture structure 200. Under the continuous downward pressure of the pressure structure, the internal lysis binding fluid will be released, and the pressure structure will maintain its final position. At the same time, the lysis binding fluid will flow out through the outlet hole at the bottom of the liquid bladder buffer chamber 1103 and enter the sample chamber 1101 through the flow channel, and then form a mixture with the biological sample in the sample chamber 1101. Due to the positive pressure in the sample chamber 1101, the mixture in the sample chamber 1101 will flow out from the second sample chamber hole 11012, and after being filtered by the filter membrane of the filter chamber 1107, it will enter the solid reagent chamber 1102. Then, the magnetic particles 1, digestive enzymes and other substances pre-loaded in the solid reagent chamber 1102 will be re-dissolved. Then, the mixture in the solid reagent chamber 1102 will flow into the first reagent chamber 11041.
[0178] Step 3: At this time, the gas drive structure inside the detection device connects with the first gas docking hole 410 on the detection chip, and at the same time, the valve control structure inside the device controls the fourth shut-off valve 540 to keep the fourth shut-off valve 540 in the closed state.
[0179] Step 4: The gas control structure inside the detection device draws a certain amount of gas from the first gas docking hole 410 of the microfluidic chip, so that all the mixture inside the sample chamber 1101 is transferred to the first reagent chamber 11041. At this time, part of the space inside the chip, such as the liquid reagent chamber 1104, will be under negative pressure.
[0180] Step 5: Maintain a negative pressure state and allow the mixture of biological sample, lysis binding solution, magnetic particles 1, and digestive enzyme to stand and incubate in the first reagent chamber 11041 for a certain period of time. The incubation process can be carried out by using equipment for heat incubation.
[0181] Step 6: Then, the detection device applies an external magnetic field above the top sealing layer a1200 above the first reagent chamber 11041 and below the bottom sealing layer 1300 below the first reagent chamber 11041. The external magnetic field can be an electromagnet or a permanent magnet. In this embodiment, a permanent magnet is preferred. The detection device moves the top magnet and the bottom magnet to positions above and below the first reagent chamber 11041.
[0182] Step 7: The top magnet moves downwards towards the top sealing layer a1200 of the first reagent chamber 11041 to attract magnetic particles 1 until the magnetic particles 1 are attracted and gathered on the side of the top sealing layer a1200 located inside the first reagent chamber 11041.
[0183] Step 8: At this time, the top magnet moves upward away from the top sealing layer a1200 of the first reagent chamber 11041, while the bottom magnet moves upward towards the bottom sealing layer 1300 of the first reagent chamber 11041, attracting the magnetic particles 1 from the top sealing layer downward to the bottom of the first reagent chamber 11041.
[0184] Step 9: Steps 9 and 10 can be repeated several times;
[0185] Step 10: The bottom magnet moves away from the bottom of the first reagent chamber 11041, and the top magnet moves close to the top of the first reagent chamber 11041, attracting the magnetic particles 1 in the first reagent chamber 11041 to the side of the top sealing layer a1200 located inside the first reagent chamber 11041.
[0186] Step 11: The gas control structure inside the detection device that is connected to the first gas connection hole 410 releases the negative pressure inside the chip, so that the gas pressure inside the microfluidic detection chip is consistent with the external ambient gas pressure and maintains a gas pressure balance.
[0187] Step 12: The detection device sequentially squeezes the fifth liquid bladder unit, the fourth liquid bladder unit, the third liquid bladder unit, and the second liquid bladder unit, transferring the pre-filled eluent, cleaning solution 3, cleaning solution 2, and cleaning solution 1 inside through the corresponding flow channels to the fifth reagent chamber 11045, the fourth reagent chamber 11044, the third reagent chamber 11043, and the second reagent chamber 11042, while maintaining the final position of the pressing structure.
[0188] Step 13: Move the top magnet horizontally and move the bottom magnet simultaneously to transfer the magnetic particle 1 through the drag channel to the first reagent buffer chamber 11051, and continue dragging it through the push channel to the top sealing layer a1200 located on the side of the second reagent chamber 11042 above the second reagent chamber 11042.
[0189] Step 14: Move the bottom magnet upwards towards the bottom sealing layer 1300 below the second reagent chamber 11042, while moving the top magnet upwards away from the top sealing layer a1200, so that the magnetic particles 1 are attracted to the bottom of the second reagent chamber 11042.
[0190] Step 15: At this time, the top magnet moves downwards towards the top sealing layer a1200 of the second reagent chamber 11042, while the bottom magnet moves away from the bottom sealing layer 1300 below the second reagent chamber 11042, attracting the magnetic particles 1 to the top sealing layer a1200 above the second reagent chamber 11042, located on the side inside the second reagent chamber 11042.
[0191] Step 16: Repeat steps 14 and 15 several times; of course, the top magnet can also be moved laterally to other positions of the top sealing layer a1200 above the second reagent chamber 11042, and steps 14 and 15 can be repeated several times to allow the magnetic particles 1 to be thoroughly cleaned in different areas of the cleaning solution 2 to remove impurities.
[0192] Step 17: Following the above method, drag the magnetic particles 1 sequentially to the third reagent chamber 11043 (inside which cleaning solution 2 has been injected) and the fourth reagent chamber 11044 (inside which cleaning solution 3 has been injected), and clean them sequentially. During this process, the magnetic particles 1 will successively pass through the second reagent buffer chamber 11052, the third reagent chamber 11043, the third reagent buffer chamber 11053, and the fourth reagent chamber 11044.
[0193] Step 18: Finally, drag magnetic particle 1 to the fifth reagent chamber 11045, and then, following the up-and-down and lateral movement of the magnet as described in steps 14, 15, and 16, release the nucleic acid adsorbed on the surface of magnetic particle 1 in the elution buffer to obtain the nucleic acid elution product. Alternatively, auxiliary equipment can be used for heat incubation during the elution process. During this period, magnetic particle 1 will successively pass through the fourth reagent buffer chamber 11054 and then enter the fifth reagent chamber 11045;
[0194] It is worth mentioning that the process of magnets adsorbing and dragging in steps 6 to 18 is shown in Figures 8 to 10.
[0195] Step 19: Maintain the adsorption state of the magnetic particles 1 in the reagent chamber by the magnet at the top of the fifth reagent chamber 11045, open the fourth shut-off valve 540, and close the first shut-off valve 510.
[0196] Step 20: The gas-driven control structure inside the detection device is connected to the first gas docking hole 410, and a certain amount of air is injected into the chip to push the nucleic acid elution product in the fifth reagent chamber 11045 through the mixing channel 1111, the mixing chamber 1108, the fourth shut-off valve 540, and the quantitative mixing chamber 1115 through the quantitative mixing chamber hole 11151 to re-dissolve the dry amplification reagent placed inside. The gas in the mixture passes through the channel through the third hydrophobic and gas-permeable membrane chamber 1116, and is discharged from the second gas docking hole 430 through the gas channel, and the fourth shut-off valve 540 is closed.
[0197] Step 21: In addition to the amplification reagent, a small ball that can be attracted by a magnet can also be placed in the quantitative mixing chamber 1115. Under the influence of the external magnet, the small ball can move up and down inside the quantitative mixing chamber 1115 to fully mix the reconstituted amplification reagent.
[0198] Step 22: Keep the fourth shut-off valve 540 closed, open the first shut-off valve 510 and the second shut-off valve 520, and close the third shut-off valve 530;
[0199] Step 23: The gas-driven control structure inside the detection device is connected to the second gas docking hole 430, and a certain amount of air is injected into it, which pushes the reconstituted amplification reagent in the quantitative mixing chamber 1115 through the quantitative mixing chamber hole 11151, the flow channel, the first shut-off valve 510 and the reaction chamber 1106 in sequence, and fills the reaction chamber 1106.
[0200] Step 24: Close the first shut-off valve 510 and the second shut-off valve 520. With the support of the detection equipment, the amplification reaction takes place inside the reaction chamber 1106;
[0201] Step 25: After the amplification reaction is completed, open the first stop valve 510 and the third stop valve 530, connect the gas drive control structure in the detection device to the second gas connection hole 430, and inject a certain amount of air into the chip so that the amplification product in the reaction chamber 1106 enters the test strip receiving chamber 1113 after passing through the third stop valve 530 for chromatography detection.
[0202] Step 26: During the chromatography detection process, the third shut-off valve 530 can be closed, or the positive pressure state in each flow channel inside the detection chip connected to the second gas docking port 430 can be maintained. In addition, according to the detection needs, a corresponding heating device can be set in the detection equipment to heat the test strip receiving cavity 1113 to maintain a certain range of chromatography temperature in the cavity, so as to make the chromatography detection more accurate.
[0203] Step 27: After the chromatography detection is completed, the internal structure of the detection equipment is reset, and the microfluidic detection chip is removed.
[0204] Example 4:
[0205] In Example 4, referring to Figures 6 and 7, a microfluidic detection chip with an added quantitative mixing chamber 1115 and its auxiliary structures was used, and the amplification results were detected using real-time fluorescence. Specifically, the solid reagent chamber 1102 of the microfluidic detection chip is pre-loaded with lyophilized magnetic particles 1, digestive enzymes (including but not limited to proteinase K, lysozyme, cell-wall-breaking enzymes, etc.), internal control materials, etc.; the liquid sac 1 is pre-loaded with lysis binding solution; the liquid sac 2 is pre-loaded with washing solution 1; the liquid sac 3 is pre-loaded with washing solution 2; the liquid sac 4 is pre-loaded with washing solution 3; the liquid sac 5 is pre-loaded with elution solution; and the amplification reagents (fluorescent PCR reagents, fluorescent isothermal amplification reagents, etc.) are pre-placed in the reaction chamber 1106 in a dry form (including but not limited to lyophilized form, air-dried form, etc.); no chromatography membrane strip is placed in the test strip receiving chamber 1113.
[0206] Step 1: Add a certain volume of biological sample (including but not limited to blood sample, respiratory sample, urine sample, fecal sample, cell culture, etc.) to the sample chamber 1101 of the microfluidic detection chip, close the chamber cover of the sample chamber 1101, insert the microfluidic detection chip into the detection device, and the device will start to run according to the set program.
[0207] Step 2: The internal pressure structure of the device will squeeze the first liquid bladder unit downwards, and the sealing membrane of the first liquid bladder unit will be punctured by the puncture structure 200. Under the continuous downward pressure of the pressure structure, the internal lysis binding fluid will be released, and the pressure structure will maintain its final position. At the same time, the lysis binding fluid will enter the sample chamber 1101 through the outlet hole at the bottom of the liquid bladder buffer chamber 1103 and flow through the channel, and then form a mixture with the biological sample in the sample chamber 1101. Due to the positive pressure in the sample chamber 1101, the mixture in the sample chamber 1101 will flow out from the sample hole, and then enter the solid reagent chamber 1102 after being filtered by the filter membrane. The magnetic particles 1, digestive enzymes and other substances pre-loaded in the solid reagent chamber 1102 will be re-dissolved. Subsequently, the mixture in the solid reagent chamber 1102 will flow into the first reagent chamber 11041 through the channel.
[0208] Step 3: At this time, the gas drive structure inside the detection device connects with the first gas docking hole 410 on the detection chip, and at the same time, the valve control structure inside the detection device controls the fourth shut-off valve 540 to keep the fourth shut-off valve 540 in the closed state.
[0209] Step 4: The gas control structure inside the detection device draws a certain amount of gas from the first gas docking hole 410, so that all the mixture inside the sample chamber 1101 is transferred to the first reagent chamber 11041. At this time, part of the space inside the chip, such as the liquid reagent chamber 1104, will be under negative pressure.
[0210] Step 5: Maintain a negative pressure state and allow the mixture of biological sample, lysis binding solution, magnetic particles 1, and digestive enzyme to stand and incubate in the first reagent chamber 11041 for a certain period of time. The incubation process can be carried out by using equipment for heat incubation.
[0211] Step 6: Then, the detection device applies an external magnetic field above the top sealing layer a1200 above the first reagent chamber 11041 and below the bottom sealing layer 1300 below the first reagent chamber 11041. The external magnetic field can be an electromagnet or a permanent magnet. In this embodiment, a permanent magnet is preferred. The detection device moves the top magnet and the bottom magnet to positions above and below the first reagent chamber 11041.
[0212] Step 7: The top magnet moves downwards towards the top sealing layer a1200 of the first reagent chamber 11041 to attract magnetic particles 1 until the magnetic particles 1 are attracted and gathered on the side of the top sealing layer a1200 located inside the first reagent chamber 11041.
[0213] Step 8: At this time, the top magnet moves upward away from the top sealing layer a1200 of the first reagent chamber 11041, while the bottom magnet moves upward towards the bottom sealing layer 1300 of the first reagent chamber 11041, so as to attract the magnetic particles 1 from the top sealing layer a1200 downward to the bottom of the first reagent chamber 11041.
[0214] Step 9: Steps 7 and 8 can be repeated several times;
[0215] Step 10: The bottom magnet moves away from the bottom of the first reagent chamber 11041, and the top magnet moves close to the top of the first reagent chamber 11041, attracting the magnetic particles 1 in the first reagent chamber 11041 to the side of the top sealing layer a1200 located inside the first reagent chamber 11041.
[0216] Step 11: The gas control structure inside the detection device that is connected to the first gas connection hole 410 releases the negative pressure inside the chip, so that the gas pressure inside the microfluidic detection chip is consistent with the external ambient gas pressure and maintains a gas pressure balance.
[0217] Step 12: The detection device sequentially squeezes the fifth liquid bladder unit, the fourth liquid bladder unit, the third liquid bladder unit, and the second liquid bladder unit, transferring the pre-filled eluent, cleaning solution 3, cleaning solution 2, and cleaning solution 1 inside them through the corresponding flow channels to the fifth reagent chamber 11045, the fourth reagent chamber 11044, the third reagent chamber 11043, and the reagent chamber 2, while maintaining the final position of the pressing structure.
[0218] Step 13: Move the top magnet horizontally and simultaneously move the bottom magnet to transfer the magnetic particle 1 through the drag channel 1 to the first reagent buffer chamber 11051, and continue dragging it through the push channel to transfer the top sealing layer a1200 above the second reagent chamber 11042 to one side of the second reagent chamber 11042.
[0219] Step 14: Move the bottom magnet upwards towards the bottom sealing layer 1300 below the second reagent chamber 11042, while moving the top magnet upwards away from the top sealing layer a1200, so that the magnetic particles 1 are attracted to the bottom of the second reagent chamber 11042.
[0220] Step 15: At this time, the top magnet moves downwards towards the top sealing layer a1200 of the second reagent chamber 11042, while the bottom magnet moves away from the bottom sealing layer 1300 below the second reagent chamber 11042, attracting the magnetic particles 1 to the top sealing layer a1200 above the second reagent chamber 11042, located on the side inside the second reagent chamber 11042.
[0221] Step 16: Repeat steps 14 and 15 several times; or move the top magnet laterally to other positions on the top sealing layer a1200 above the second reagent chamber 11042 and repeat steps 14 and 15 several times to ensure that the magnetic particles 1 are thoroughly cleaned in different areas of the cleaning solution 2 in the second reagent chamber 11042 to remove impurities.
[0222] Step 17: Following the method described above, drag the magnetic particles 1 sequentially to the third reagent chamber 11043 (inside which cleaning solution 2 has been injected) and the fourth reagent chamber 11044 (inside which cleaning solution 3 has been injected), and clean them sequentially. During this process, the magnetic particles 1 will successively pass through the dragging channel, the second reagent buffer chamber 11052, the dragging channel, the third reagent chamber 11043, the dragging channel, the third reagent buffer chamber 11053, the dragging channel, and the fourth reagent chamber 11044.
[0223] Step 18: Finally, drag the magnetic particle 1 to the fifth reagent chamber 11045, and then, following the method of moving the magnet up and down and laterally as described in steps 14, 15 and 16, release the nucleic acid adsorbed on the surface of the magnetic particle 1 in the elution solution to obtain the nucleic acid elution product.
[0224] The elution process can also be carried out by auxiliary equipment for thermal incubation. During this period, the magnetic particles 1 will pass through the dragging channel 7 and the fourth reagent buffer chamber 11054 in succession, and then enter the fifth reagent chamber 11045; the process of magnet adsorption and dragging in steps 6 to 18 is shown in Figures 8 to 10.
[0225] Step 19: Maintain the adsorption state of the magnet at the top of the fifth reagent chamber on the magnetic particles 1 in the reagent chamber, open the fourth shut-off valve 540, and close the first shut-off valve 510;
[0226] Step 20: The gas-driven control structure inside the detection device docks with the first gas docking port 410 and injects a certain amount of air into the chip, pushing the nucleic acid elution product in the fifth reagent chamber 11045 through the mixing channel 1111, the mixing chamber 1108, the fourth shut-off valve 540 in sequence, and entering the quantitative mixing chamber 1115 through the quantitative mixing chamber port 11151, re-dissolving the dry amplification reagent placed inside. The gas in it passes through the channel, the hydrophobic and gas-permeable membrane, and the gas channel, and finally exits from the second gas docking port 430.
[0227] Step 21: In addition to the amplification reagent, a small ball that can be attracted by a magnet can also be placed in the quantitative mixing chamber 1115. Under the influence of the external magnet, the small ball can move up and down inside the quantitative mixing chamber 1115 to fully mix the reconstituted amplification reagent.
[0228] Step 22: Keep the fourth shut-off valve 540 closed, open the first shut-off valve 510 and the second shut-off valve 520, and close the third shut-off valve 530;
[0229] Step 23: The gas-driven control structure inside the detection device is connected to the second gas docking hole 430, and a certain amount of air is injected into it to push the reconstituted liquid amplification reagent in the quantitative mixing chamber 1115 through the quantitative mixing chamber hole 11151, the first shut-off valve 510, and the reaction chamber 1106 in sequence, and fill the reaction chamber 1106.
[0230] Step 24: Close the first shut-off valve 510 and the second shut-off valve 520. With the support of the detection equipment, the amplification reaction takes place inside the reaction chamber 1106; and the detection equipment performs real-time fluorescence detection.
[0231] Step 25: The test is completed. The internal structure of the test equipment is reset, and the microfluidic test chip is removed.
[0232] Microfluidic detection chip example 5:
[0233] In Example 5, the other drying reagents, except for magnetic particles 1, can be selectively placed in the sample cavity 1101, including digestive enzymes, internal control materials, and some lysis binding solution components that can be stored in a dry form. The rest of the process is basically the same as in Examples 1, 2, 3, and 4.
[0234] Example 6:
[0235] In Example 6, a microfluidic detection chip with an added quantitative mixing chamber 1115 and its auxiliary structures was used, as shown in Figures 6 and 7. The nucleic acid elution product in the fifth reagent chamber 11045 can be transferred to the quantitative mixing chamber 1115 via the following process: after reconstitution and mixing, it is further transferred to the reaction chamber 1106. The specific steps are as follows:
[0236] Step 1: Open the fourth shut-off valve 540 and close the first shut-off valve 510;
[0237] Step 2: By detecting the gas drive control structure inside the device, the first gas docking hole 410 is made open (i.e., the first gas docking hole 410 is connected to the external atmospheric environment of the chip).
[0238] Step 3: The gas-driven control structure inside the detection device is connected to the second gas docking port 430, and a certain amount of gas is drawn from the chip, so that the nucleic acid elution product in the fifth reagent chamber 11045 passes through the outlet port, flow channel, mixing flow channel 1111, mixing chamber, fourth shut-off valve 540, and enters the quantitative mixing chamber 1115 through the quantitative mixing chamber port 11151, where it is reconstituted and mixed with the dry amplification reagent placed inside.
[0239] Step 4: Close the fourth shut-off valve 540 and the third shut-off valve 530, and open the first shut-off valve 510 and the second shut-off valve 520;
[0240] Step 5: The gas-driven control structure inside the detection device is connected to the gas docking hole 2, and a certain amount of air is injected into it to push the reconstituted liquid amplification reagent in the quantitative mixing chamber 1115 through the quantitative mixing chamber hole 11151, the flow channel, the first shut-off valve 510, and then into the reaction chamber 1106.
[0241] Example 7:
[0242] In Example 7, a microfluidic detection chip with an added quantitative mixing chamber 1115 and its auxiliary structures was used, as shown in Figures 6 and 7. The nucleic acid elution product in the fifth reagent chamber 11045 can be transferred to the quantitative mixing chamber 1115 via the following process: after reconstitution and mixing, it is further transferred to the reaction chamber 1106. The specific steps are as follows:
[0243] Step 1: Open the fourth shut-off valve 540 and close the first shut-off valve 510;
[0244] Step 2: By detecting the gas drive control structure inside the device, the first gas docking hole 410 is made open (i.e., the first gas docking hole is connected to the external atmospheric environment of the chip 410).
[0245] Step 3: The gas-driven control structure inside the detection device is connected to the second gas docking port 430, and a certain amount of gas is drawn from the chip, so that the nucleic acid elution product in the fifth reagent chamber 11045 passes through the outlet port, flow channel, mixing flow channel 1111, mixing chamber, fourth stop valve 540, and enters the quantitative mixing chamber 1115 through the quantitative mixing chamber port 11151, where it is reconstituted and mixed with the dry amplification reagent placed inside.
[0246] Step 4: Close the fourth shut-off valve 540 and the third shut-off valve 530, and open the first shut-off valve 510 and the second shut-off valve 520.
[0247] Step 5: By detecting the gas drive control structure inside the device, the second gas docking hole 430 is made open (i.e., the second gas docking hole 430 is connected to the external atmospheric environment of the chip).
[0248] Step 6: The gas-driven control structure inside the detection device is connected to the gas port 420 and a certain amount of gas is drawn from the chip, so that the liquid in the quantitative mixing chamber 1115 passes through the flow channel and the first shut-off valve 510 and then enters the reaction chamber 1106.
[0249] Example 8:
[0250] In Example 8, a microfluidic detection chip without the added quantitative mixing chamber 1115 and its auxiliary structures is used. The nucleic acid elution product in the fifth reagent chamber 11045 can be transferred to the reaction chamber 1106 via the following process. The steps of this example are as follows:
[0251] Step 1: Open the first shut-off valve 510 and the second shut-off valve 520, and close the third shut-off valve 530;
[0252] Step 2: By detecting the gas drive control structure inside the device, the first gas docking hole 410 is made open (i.e., the first gas docking hole 410 is connected to the external atmospheric environment of the chip).
[0253] Step 3: The gas-driven control structure inside the detection device is connected to the gas vent 420 and a certain amount of gas is drawn from the chip, so that the nucleic acid elution product in the fifth reagent chamber 11045 enters the reaction chamber 1106 through the flow channel, the mixing flow channel 1111, the mixing chamber, the first shut-off valve 510, and the flow channel, and fills the reaction chamber 1106.
[0254] Example 9:
[0255] In Example 9, a microfluidic detection chip with an added quantitative mixing chamber 1115 and its auxiliary structures is used, as shown in Figures 6 and 7. After the amplification reaction is complete, the amplification product in reaction chamber 1106 can be transferred to the test strip receiving chamber 1113 via the following process. The steps of this example are as follows:
[0256] Step 1) After the amplification reaction is completed, open the fourth cutoff valve 540, the first cutoff valve 510 and the third cutoff valve 530, and keep the second cutoff valve 520 closed.
[0257] Step 2) By detecting the gas drive control structure inside the device, the second gas docking hole 430 is closed (i.e., the second gas docking hole 430 is not connected to the external atmospheric environment of the chip).
[0258] Step 3) The gas-driven control structure inside the detection device docks with the first gas docking hole 410 and injects a certain amount of air into the chip, so that the amplification product of the reaction chamber 1106 is transferred to the test strip receiving chamber 1113.
[0259] Example 10:
[0260] When transferring liquid using the methods described in Examples 6, 7, and 8, it is not necessary to maintain the final position of the liquid bladder pressure structure; and the number of pressure structures can be reduced, such as using only one pressure structure, and the same pressure structure can be reused through the relative movement between the chip and the pressure structure.
[0261] Example 11:
[0262] In Example 11, the magnetic particles 1 can be placed in the sample chamber 1101 in a solid, dry form or in a liquid form in the liquid sac unit (such as the first liquid sac unit). If placed in the liquid sac unit, the magnetic beads settled in the liquid sac can be manually shaken, resuspended, and mixed before use; alternatively, after inserting the microfluidic detection chip into the instrument, the magnetic particles can be resuspended and mixed by the instrument's vibration.
[0263] Example 12:
[0264] The detection device paired with the microfluidic chip in this application has multiple functional modules, including but not limited to a nucleic acid extraction module (liquid bladder compression module, magnet module), a thermal incubation module (to assist nucleic acid extraction and membrane strip chromatography process), a valve control module, a mechanical transmission module, a gas drive control module (wherein the gas drive control structure of the detection device and the microfluidic detection chip can have multiple docking structures to meet the transfer and control of fluid within the detection chip), a temperature control module (to support amplification reaction), a fluorescence acquisition and analysis module (for fluorescence detection schemes), an image acquisition and analysis module (for chromatography detection schemes), a software system, a hardware system, and a user interface.
[0265] In the description of this application, it should be understood that the terms "center", "upper", "lower", "front", "rear", "left", "right", "vertical", "horizontal", "top", "bottom", "inner", "outer", etc., indicate the orientation or positional relationship based on the orientation or positional relationship shown in the accompanying drawings. They are only for the convenience of describing this application and simplifying the description, and do not indicate or imply that the device or element referred to must have a specific orientation, or be constructed and operated in a specific orientation. Therefore, they should not be construed as limitations on this application.
[0266] The terms "first" and "second" are used for descriptive purposes only and should not be construed as indicating or implying relative importance or implicitly specifying the number of technical features indicated. Therefore, a feature defined as "first" or "second" may explicitly or implicitly include one or more of that feature. In the description of this application, unless otherwise stated, "a plurality of" means two or more.
[0267] In the description of this application, it should be noted that, unless otherwise expressly specified and limited, the terms "installation," "connection," and "joining" should be interpreted broadly. For example, they can refer to a fixed connection, a detachable connection, or an integral connection; they can refer to a direct connection or an indirect connection through an intermediate medium; and they can refer to the internal connection between two components. Those skilled in the art can understand the specific meaning of the above terms in this application based on the specific circumstances.
[0268] In the description of this specification, specific features, structures, materials, or characteristics may be combined in any suitable manner in one or more embodiments or examples.
[0269] It should be understood that although the steps in the flowcharts of the accompanying figures are shown sequentially as indicated by the arrows, these steps are not necessarily executed in the order indicated by the arrows. Unless explicitly stated herein, there is no strict order restriction on the execution of these steps, and they can be executed in other orders. Moreover, at least some steps in the flowcharts of the accompanying figures may include multiple sub-steps or multiple stages. These sub-steps or stages are not necessarily completed at the same time, but can be executed at different times, and their execution order is not necessarily sequential, but can be performed alternately or in turn with other steps or at least some of the sub-steps or stages of other steps.
Claims
1. A microfluidic detection chip, characterized in that, include: A microfluidic layer includes a substrate and a top sealing layer and a bottom sealing layer located on both sides of the substrate. The substrate is provided with a sample chamber, a solid reagent chamber, a liquid bladder buffer chamber, a liquid reagent chamber, a reagent buffer chamber, and a reaction chamber. The sample chamber is connected to the solid reagent chamber through a flow channel. There are multiple liquid bladder buffer chambers, which are independently arranged. There are multiple liquid reagent chambers, which are arranged sequentially at intervals. At least one reagent buffer chamber is arranged between two adjacent liquid reagent chambers. The first liquid reagent chamber at the front end is connected to the solid reagent chamber via a flow channel, and the liquid reagent chamber at the end end is connected to the reaction chamber via a flow channel; one of the liquid bladder buffer chambers is in fluid communication with one of the sample chamber and the first liquid reagent chamber; except for the first liquid reagent chamber at the front end, each of the remaining liquid reagent chambers is connected to a different liquid bladder buffer chamber via a flow channel. The puncture structure is provided in each of the liquid bladder buffer cavities; A liquid bladder layer is disposed on one side of the substrate. The liquid bladder layer includes a plurality of spaced and independent liquid bladder units. Each liquid bladder unit has a liquid bladder cavity, and the liquid bladder cavity of the liquid bladder unit is disposed opposite to at least one of the puncture structures.
2. The microfluidic detection chip according to claim 1, characterized in that, The substrate is provided with a first gas connection hole and a first shut-off valve. The first gas connection hole is in fluid communication with the second liquid reagent chamber located at the front end. The first shut-off valve is used to control the opening and closing of the flow channel connected to the liquid inlet end of the reaction chamber.
3. The microfluidic detection chip according to claim 2, wherein, The substrate is provided with a mixing channel and a mixing chamber. One end of the mixing channel is in liquid communication with the liquid reagent chamber located at the end. The other end of the mixing channel is in liquid communication with the inlet end of the mixing chamber. The outlet end of the mixing chamber is in liquid communication with the inlet end of the first shut-off valve.
4. The microfluidic detection chip according to claim 2 or 3, characterized in that, The substrate is provided with a test strip receiving cavity, an air hole, a second shut-off valve, and a third shut-off valve. The test strip receiving cavity is in liquid communication with the liquid outlet of the reaction chamber through a flow channel, and the air hole is in fluid communication with the liquid outlet of the reaction chamber through a flow channel. The second shut-off valve is used to control the opening and closing of the flow channel between the liquid outlet of the reaction chamber and the air hole, and the third shut-off valve is used to control the opening and closing of the flow channel between the test strip receiving cavity and the liquid outlet of the reaction chamber.
5. The microfluidic detection chip according to claim 4, characterized in that, The substrate is provided with a fourth shut-off valve, a quantitative mixing chamber, and a second gas connection hole. The fourth shut-off valve is disposed on a flow channel that communicates with the liquid inlet end of the first shut-off valve. The quantitative mixing chamber hole of the quantitative mixing chamber is in fluid communication with the liquid outlet end of the fourth shut-off valve. The top of the quantitative mixing chamber is connected to the second gas connection hole through a flow channel.
6. The microfluidic detection chip of claim 1, wherein, The reaction chamber is flat, and at least one cavity is provided on the outer periphery of the reaction chamber.
7. The microfluidic detection chip according to claim 1 or 6, characterized in that, The number of reaction chambers is at least one.
8. The microfluidic detection chip according to claim 7, characterized in that, The substrate includes a first part and a second part that are connected to each other. The thickness of the second part is less than the thickness of the first part. The reaction chamber is disposed in the second part and extends through the upper and lower surfaces of the second part.
9. The microfluidic detection chip of claim 1, wherein, The liquid bladder unit includes a liquid bladder shell and a liquid bladder sealing membrane. The liquid bladder shell forms an open liquid bladder cavity, and the liquid bladder sealing membrane is disposed on the side of the liquid bladder cavity with the open.
10. A method of detection, characterized in that, Applied to the microfluidic detection chip as described in any one of claims 1 to 9, the detection method includes the following steps: Place the biological sample into the sample chamber and close the sample chamber; Squeeze the liquid capsule unit connected to the sample cavity to allow the reagent in the liquid capsule unit to flow into the sample cavity and mix with the biological sample; The mixed solution in the sample chamber is driven to flow to the solid reagent chamber to redissolve the solid reagent preset in the solid reagent chamber to obtain a mixture, wherein the solid reagent chamber is also preset with magnetic particles; The mixture in the solid reagent chamber is forced into the first liquid reagent chamber and allowed to stand. The first and second magnetic components are controlled to approach the top and / or bottom of the liquid reagent chamber, and the first and second magnetic components are used to drive the magnetic particles in the liquid reagent chamber to pass through each of the liquid reagent chambers and the reagent buffer chamber in sequence, and drive the magnetic particles to finally move to the liquid reagent chamber located at the end. Maintaining the adsorption state of the magnetic particles by the first magnetic element, the elution product in the liquid reagent chamber at the end is driven into the reaction chamber to carry out the amplification reaction.
11. A detection device, characterized by include: At least one pressure structure is used to compress the individual liquid bladder units of the liquid bladder layer; A magnetic component, comprising a first magnetic element and a second magnetic element spaced apart; A driving device is used to drive a first magnetic component to move, such that the first magnetic component moves in a direction perpendicular to the microfluidic detection chip. The driving device is also used to drive the first magnetic component to move laterally along an end face parallel to the microfluidic detection chip. The driving device is also used to drive a second magnetic component to move, such that the second magnetic component moves in a direction perpendicular to the microfluidic detection chip. The driving device is also used to drive the second magnetic component to move laterally along an end face parallel to the microfluidic detection chip.
12. The detection device according to claim 11, characterized in that The detection device includes a gas-driven control structure, which is used to draw or blow air into the docking hole in the microfluidic detection chip. The gas-driven control structure is also used to control the opening and closing of the docking hole.
